Dermira's currently running unbranded advertising to raise awareness about hyperhidrosis, or excessive sweating, will run concurrently with branded ads in the works.
Dermira announced the U.S. Food and Drug Administration (FDA) has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.